Kerry Rogers, MD | Authors


Lead-In Treatment to Reduce Tumor Lysis Syndrome Risk in CLL

August 21, 2018

Kerry Rogers, MD, assistant professor at The Ohio State University Comprehensive Cancer Center, discusses a short-term treatment strategy for reducing tumor burden and the risk for tumor lysis syndrome in patients with chronic lymphocytic leukemia.